This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (18)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Gerald S. Wilson, MD; Marvin A. Rich, PhD; Michael J. Brennan, MD

Arch Surg. 1980;115(4):415-419.

Abstract
• Two hundred and thirty-five patients underwent a bone scan prior to, or within two weeks of, instituting surgical treatment for cancer of the breast. These patients were staged clinically according to the TNM classification. There were three patients with abnormal bone scans of a total of 173 patients in clinical stages I and II; none of 86 patients had stage I disease and only three of 87 patients had stage II disease. The conclusion from the study is that routine preoperative bone scans are of no value for staging purposes in patients with clinical stage I disease. In clinical stage II, bone scans are difficult to justify, considering the low yield (3.4%) and the cost per abnormal scan.

(Arch Surg 115:415-419, 1980)

Author Affiliations
From the Michigan Cancer Foundation Breast Prognostic Study, Michigan Cancer Foundation, Detroit.

Footnotes
Accepted for publication Dec 20, 1979.

Read before the 87th annual meeting of the Western Surgical Association, Colorado Springs, Colo, Nov 12, 1979.

Reprint requests to 18161 W 13 Mile Rd, Southfield, MI 48076 (Dr Wilson).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Baseline staging tests in primary breast cancer: a practice guideline
Myers et al.
CMAJ 2001;164:1439-1444.
ABSTRACT | FULL TEXT  

Evaluation of Staging Workup in Malignant Melanoma
Khansur et al.
Arch Surg 1989;124:847-849.
ABSTRACT